(2S,5S,8S,11S,14S,17S,20S,23S)-23-氨基-14-(2-氨基-2-氧代乙基)-5-(4-氨基丁基)-11-苄基-17,20-二((S)-仲丁基)-8-(2-羧乙基)-24-羟基-2-异丁基-4,7,10,13,16,19,22-七氧代-3,6,9,12,15,18,21-七氮杂二十四烷酸; H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH; OVA PEPTIDE (257-264)肽; 卵清蛋白三氟乙酸盐(OVA PEPTIDE 257-264); (2S,5S,8S,11S,14S,17S,20S,23S)-23-Amino-14-(2-amino-2-oxoethyl)-5-(4-aminobutyl)-11-benzyl-17,20-di((S)-sec-butyl)-8-(2-carboxyethyl)-24-hydroxy-2-isobutyl-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazatetracosanoic acid; H-Ser-ile-ile-asn-phe-glu-lys-leu-OH; H-SIINFEKL-OH; Ovalbumin (257-264); OVALBUMIN(257-264) ANTIGEN PEPTIDE; OVA PEPTIDE (257-264); SIINFEKL; CHICKEN OVALBUMIN FRAGMENT (257-264); SER-ILE-ILE-ASN-PHE-GLU-LYS-LEU; OVA (257-264); OVA (257-264) (CHICKEN); OT I Peptide; OVA Peptide(257-264); OVA Peptide 257-264
用途
OVA Peptide(257-264) 是 OVA 的 I 类 (Kb)-限制性肽表位，是一种八聚体肽，用于研究 TAP1-I- and C57BL/6 macrophages 对 Crl-OVA 和全长 OVA 的加工及 MHC I 类呈递中 TAP 转运体的依赖性，其在不同蛋白背景下的呈递特性具有研究价值。
bis(2,2,6,6-tetramethylpiperidin-4-yl) decanedioate compound with 15,35,55,75-tetra-tert-butyl-1,3,5,7(1,3)-tetrabenzenacyclooctaphane-12,32,52,72-tetraol
15,35,55,75,95,115,135,155-octa-tert-butyl-1,3,5,7,9,11,13,15(1,3)-octabenzenacyclohexadecaphan-12,32,52,72,92,112,132,152-octaol compound with 2,2,6,6-tetramethylpiperidin-4-amine (1:1)
